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Background: Hypersentivity Syndrome (HS) may be a life-threatening condition. It frequently
presents with fever, rash, eosinophilia and systemic manifestations. Mortality can be as high as 10%
and is primarily due to hepatic failure. We describe what we believe to be the first case of
minocycline-induced HS with accompanying lymphocytic meningitis and cerebral edema reported
in the literature.
Case presentation: A 31-year-old HIV-positive female of African origin presented with acute
fever, lymphocytic meningitis, brain edema, rash, eosinophilia, and cytolytic hepatitis. She had been
started on minocycline for inflammatory acne 21 days prior to the onset of symptoms. HS was
diagnosed clinically and after exclusion of infectious causes. Minocycline was withdrawn and
steroids were administered from the second day after presentation because of the severity of the
symptoms. All signs resolved by the seventh day and steroids were tailed off over a period of 8
months.
Conclusion: Clinicians should maintain a high index of suspicion for serious adverse reactions to
minocycline including lymphocytic meningitis and cerebral edema among HIV-positive patients,
especially if they are of African origin. Safer alternatives should be considered for treatment of acne
vulgaris. Early recognition of the symptoms and prompt withdrawal of the drug are important to
improve the outcome.
Background
Hypersentivity Syndrome (HS) is a rare and life-threaten-
ing form of drug reaction [1]. Usual presentation includes
fever, rash, eosinophilia and systemic manifestations.
Mortality may be as high as 10% and is primarily due to
hepatic failure [2]. HS is frequently associated with the use
of sulfonamides, allopurinol, terbinafine, minocycline,
and antiretroviral therapy [3].
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Minocycline is widely prescribed for the treatment of
inflammatory forms of acne vulgaris [4]. Although it is
considered to be a safe drug [2], it has been reported to
cause serious adverse events such as hepatitis, auto-
immune syndrome and HS [1,5]. To our knowledge, lym-
phocytic meningitis and brain edema associated with
minocycline-induced HS have not been reported in the lit-
erature. This presentation, which is probably under-recog-
nized, may lead to a diagnostic delay. We report herein
one case.
Case presentation
A 31-year-old female native of Africa was hospitalized
with fever, weakness, nausea, headache, facial edema, and
rash, for 4 days. She had been diagnosed as HIV positive
2 years previously. CD4 cell count was between 300 and
400 cells/mm3, viral load was near 150,000 copies/mm3,
both steady for several weeks. She had no other relevant
medical history, and was on no treatment for HIV. Three
weeks before the onset of the symptoms, she had been
started on oral minocycline to control an inflammatory
form of acne vulgaris.
At admittance she was unwell and vital signs were: blood
pressure 100/60, temperature 40°C, heart rate 120 beats/
min., respiratory rate 22/min., and oxygen saturation 97%
(room air). On physical examination, she had multiple
erythematous, oedematous and coalescing plaques on the
upper trunk, and on proximal segments of the limbs. Her
palms and soles were erythematous. She also had injec-
tion of the sclera, and edema of the eyelids. Buccal and
genital mucous membranes were unaffected. Palpation
revealed enlarged tender lymph nodes at all sites, but no
accompanying hepatomegaly or splenomegaly. Cardio-
vascular and pulmonary systems were normal, with no
sign of septic shock. Neurological examination was nor-
mal.
Laboratory tests revealed the following values: leucocyto-
sis (24×109/L), eosinophilia (2.8×109/L), neutrophilia
(8×109/L) without lymphocytosis (2.8×109/L), elevated
C-Reactive Protein (17 mg/L) and cytolytic hepatitis (ALT
160 U/L, AST 106 U/L, lactate deshydrogenase 1400 U/L
(LDH)). Multiple blood culture and bacteriological anal-
ysis of urine were sterile. Serological investigation for viral
and bacterial agents, repeated over two weeks showed no
sign of recent infection (Borrelia burgdorferi, Mycoplasma
sp.,  Chlamydiae sp., Legionella sp., Epstein-Barr virus,
cytomegalovirus, hepatitis A, B and C viruses, measles,
rubella, parvovirus B19, coxsackievirus, echovirus, VZV,
HTLV1, HSV, toxoplasmosis). The antinuclear antibodies
were negative. Chest radiography and echocardiography
showed no abnormalities, however cerebral CT-scan
showed a diffuse cerebral edema (figure). Electroencepha-
logram was normal. The lumbar puncture revealed lym-
phocytic meningitis with 60 cells/microliter
(lymphocytes: 90%, protein level: 0.80 g/L, glucose level:
0.56 g/L). No microbial agents were found in the cerebro-
spinal fluid (cryptococcal antigen and culture, culture for
bacteriological agents, and polymerase chain reaction
(PCR) for echovirus, coxackies virus, CMV, HSV, VZV).
PCR for HIV in cerebrospinal fluid was not performed.
Histopathology of a skin biopsy sample showed a lym-
phocytic infiltrate into the dermo-epidermis junction
with edema, resulting in a blister detachment. This aspect
was of a lichenoid toxiderma. Lymph node biopsy was not
performed.
Minocycline was discontinued on the fourth day after the
onset of the symptoms. Two days after minocycline with-
drawal, treatment with steroids was introduced (methyl-
prednisolone 60 mg daily) because of the severity of the
symptoms. The patient improved quickly after steroid
administration. Temperature dropped to 37°C within
three days. Within one week the eruption cleared and lym-
phadenopathies disappeared. Biological abnormalities
(eosinophilia, liver enzyme elevation) resolved within
three days. A second brain CT-scan, undertaken 14 days
after the onset of the symptoms, was normal. Lumbar
puncture was not repeated. The steroids were steadily
tailed off (5 mg per week) but a relapse occurred on week
6, when on a dose of 30 mg per day. This relapse was
under the form of a transient and isolated generalized pru-
ritus with no cutaneous nor neurological signs. Skin tests
were not carried out due to the potential risk of severe
reaction. The patient was weaned off steroids over a
period of 8 months and was free of symptoms at dis-
charged form care.
Discussion
Minocycline is widely prescribed for acne vulgaris [4].
Minor adverse effects including nausea, vomiting, dizzi-
ness, photosensitivity and skin eruption have been
described [2]. However, acute and severe reactions such as
HS, autoimmune disorders, serum sickness like reaction,
and pseudotumor cerebri syndrome have also been
reported [1,5-8].
The case described had several features suggesting a diag-
nosis of HS secondary to minocycline treatment. The his-
tory was characteristic (interval of 3 weeks between the
introduction of the drug and the symptoms) and the con-
dition resolved promptly following cessation of minocy-
cline. Moreover, differential diagnoses due to the most
likely infectious diseases were excluded and no evidence
of pseudotumor cerebri syndrome, as it may be observed
with minocycline, was found. While lymphocytic menin-
gitis and cerebral edema have not been described in asso-
ciation with minocycline-induced HS, they have been
reported following use of allopurinol [9].Journal of Medical Case Reports 2007, 1:22 http://www.jmedicalcasereports.com/content/1/1/22
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HS to minocycline is a nosological entity also called
DRESS syndrome (Drug Reaction with Eosinophilia and
Systemic Symptoms). It occurs within 3 to 4 weeks after
starting therapy, usually in a young patient (21.2 ± 1.8
years-old) [1,5]. As in our patient, HIV-infection and
black African origin have been suggested as risk factors for
minocycline HS [3]. Clinical features include three major
elements: (1) high fever with asthenia; (2) acute general-
ized cutaneous signs often polymorphous (maculo-papu-
lar rash sometimes morbiliform, exanthematous, or
multiform); facial edema is evocative and intense pruritus
is common; and (3) multivisceral involvement [3,5,10].
The most common visceral signs are enlargement of the
lymph nodes, hepatomegaly and splenomegaly [1,5].
Severe reactions may lead to hepatitis, pulmonary infil-
trates with eosinophilia, myocarditis and interstitial
nephritis [1,8]. In 1996, among 13 cases of HS reaction
due to minocycline, none had cerebral involvement [1].
Suggestive blood chemistry includes eosinophilia (often
over 1.5×109/L), cytolytic hepatitis (from mild elevation
of liver enzyme to severe liver failure), LDH elevation and
hemolytic anaemia [1,10]. The skin biopsy may show a
non specific lymphocytic infiltrate or lichenoid interface
dermatitis [1]. The treatment is usually limited to the
withdrawal of minocycline, which is usually followed by
symptomatic relief [5]. Steroids should be restricted to
severe case with threatening renal, liver or lung involve-
ment. They should be used with caution because depend-
ence to steroid is frequent and rebound of the condition
may follow their withdrawal, as observed in this case
report.
Conclusion
As minocycline is a widely used drug, clinicians should be
aware of the risk of HS, even in the presence of neurolog-
ical abnormalities. Early warning signs include an acute
rash with fever, eosinophilia and elevated liver enzymes.
The drug should be immediately and definitively with-
drawn for the patient. If used, minocycline should be
strictly monitored, especially in African or HIV-infected
patients.
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